企業プロフィール
Travere Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- TVTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
65.22 USD (-0.75%)
終値
最終更新: 2026年8月24日
3.99B USD
時価総額
株価変動の要因
As of Aug 24, 2026, TVTX closed down 0.75% at $65.22. No new same-company headline was identified in the current news window.
企業概要
事業概要
Travere Therapeutics is a rare-disease company with a focus on kidney and hepatology programs. Its business combines commercial execution with pipeline development in hard-to-treat diseases.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Travere sits in specialty biopharma.
ビジネスモデルの特徴
The model is driven by product adoption, label expansion, and development in additional rare disease settings.
バイオ業界での位置付け
Travere is a specialty-rare-disease name whose stock can move on both commercial traction and pipeline progress.
今後のカタリスト
- Travere's catalysts are FILSPARI execution in IgA nephropathy and any FSGS or label-expansion step that widens the renal franchise. The company improves when the nephrology story keeps compounding.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。